Morning Movers Gapping up $迪士尼(DIS.US)$'s stock enjoyed a 1.2% increase after a company spokesperson responded to activist investor Nelson Peltz's criticisms regarding the company's movie casting choices, using it as a reason to argue against his appointment to Disney's board. $麦斯莫医疗(MASI.US)$'s stock surged by 13% on news from the Wall Street Journal that Politan Capital Management is looking to propose two additional m...
BioNTech's revenue forecasts have been downgraded, with earnings outlook slashed from profit to loss. The company's revenues are expected to underperform the wider industry, leading to increased pessimism about the business's intrinsic value.
BioNTech's Q4 results were hit by Pfizer's inventory writedowns. Despite a drop in vaccine sales, it remains a leader in the COVID-19 vaccine market and is advancing in cancer treatments. Lower-than-expected earnings and revenue, along with fewer vaccine doses delivered, could hurt the stock.
Morning Movers Gapping up $英伟达(NVDA.US)$stock rose 0.3% in volatile trading after the chipmaker revealed pricing and shipment plans for its anticipated Blackwell B200 chip. $英特尔(INTC.US)$stock rose 3.6% after the Biden administration announced it is awarding the tech giant nearly $20 billion in grants and loans to boost the country's chip output. $特斯拉(TSLA.US)$stock rose 0.6% after confirming a price increase for China...
BelleWeatherChiu fong Ko:
Yes, I was burned by accounting fraud with Chinese companies when I first started investing in earnest. So no matter how cheap a Chinese company looks, I’m not interested now. And of course all the political risk with both governments. I’d liked PDD for a big data play - that’s how they make money. And yeah, ignore buy (and sell) side analysts - they are trying to manipulate price for their own benefit and many of them have awful track records, like average gain -26 with 12% accuracy is at best a contrarian indicator!
BioNTech's low P/E ratio is attributed to investors' expectations of continued poor earnings. Shareholders accept this low P/E, anticipating no pleasant surprises in future earnings, suggesting a stagnant share price.
BioNTech股票讨论区
📊⚡️📊
新增数据:23Q3,23Q4,营收、营业利润和净利润均持续萎缩,但是环比来看连续大幅改善两个季度。
2023年营收萎缩78%,营业利润萎缩92.7%,净利润萎缩90.1%。
资产负债率从13.9%下降到12%,总资产略有下降,净资产略有增长。资产端现金增长,应收大幅下降,负债端有息负债依然很少可以忽略。
现金流经营净额低于投资净额,没有产生股东盈余,不过5年累计产生了不少。
目前市盈率21.4,如果按照目前的改善趋势,2024年净利润应该可以达到20亿左右,市盈率会下降到10左右,估值依然不高,可以谨慎选择(⭐️)
Gapping up
$迪士尼(DIS.US)$ 's stock enjoyed a 1.2% increase after a company spokesperson responded to activist investor Nelson Peltz's criticisms regarding the company's movie casting choices, using it as a reason to argue against his appointment to Disney's board.
$麦斯莫医疗(MASI.US)$ 's stock surged by 13% on news from the Wall Street Journal that Politan Capital Management is looking to propose two additional m...
Gapping up
$英伟达(NVDA.US)$ stock rose 0.3% in volatile trading after the chipmaker revealed pricing and shipment plans for its anticipated Blackwell B200 chip.
$英特尔(INTC.US)$ stock rose 3.6% after the Biden administration announced it is awarding the tech giant nearly $20 billion in grants and loans to boost the country's chip output.
$特斯拉(TSLA.US)$ stock rose 0.6% after confirming a price increase for China...
Monday will see $Bit Digital(BTBT.US)$ set the tone for the week, followed by announcements from $小鹏汽车(XPEV.US)$ and $TeraWulf(WULF.US)$ on Tuesday. Wednesday's lineup features $拼多多(PDD.US)$, $美光科技(MU.US)$, and $BioNTech(BNTX.US)$, while Thursday's roster includes $埃森哲(ACN.US)$, ...
暂无评论